Barclays Investment Banking Interview Questions & Answers

Build a 90-second narrative: academic foundation, analytical evidence, relevant experiences and why advisory banking now. Finish with why this team.

Give a specific, researched answer about the firm’s advisory franchise, a relevant sector or transaction, and your fit. Avoid claiming a deal without checking its public details.

Contrast transaction execution and financial advisory with investing or strategic consulting; demonstrate awareness of the hours and analytical demands.

Connect sector trends to a recent verified deal and show how your prior experience prepares you to contribute.

Use STAR and show how you changed behaviour and measured improvement.

Explain prioritisation, accuracy controls, stakeholder updates and the outcome.

Show active listening, clear decision criteria, compromise and accountability.

Explain strategic rationale, enterprise value, financing, valuation and regulatory or integration risks.

Support both with evidence and show a concrete improvement plan.

Explain assumptions, scenario analysis, risk flags and what you would verify next.

Net income links income statement to cash flow and retained earnings; cash flow links to balance sheet cash; capex and depreciation change PP&E.

EBIT and pretax income fall £10; net income falls £7.5; CFO increases £2.5 after adding back D&A and tax saving; PP&E falls £10, cash rises £2.5, equity falls £7.5.

Higher capex, working capital investment, cash taxes, interest or lower cash conversion.

Working capital investment uses cash, all else equal; distinguish an increase caused by sales from deteriorating collections.

Goodwill generally arises when consideration exceeds the fair value of identifiable net assets acquired, after relevant accounting adjustments.

Cash collected before revenue recognition; a liability until the performance obligation is satisfied.

EBIT×(1−tax rate)+D&A−capex−change in net working capital.

Accrual timing, noncash expenses, capex, financing flows and working capital movements.

Forecast UFCF, discount at WACC, calculate terminal value, derive enterprise value, bridge to equity and divide by diluted shares.

Comparable companies, precedent transactions and DCF; discuss when each is more or less reliable.

Weight cost of equity and after-tax cost of debt by market-value capital structure; explain beta, risk-free rate and equity risk premium.

Discounted cash flows and terminal value typically decline, lowering enterprise value.

Perpetuity growth UFCF(n+1)/(WACC−g), or an exit EBITDA multiple; cross-check assumptions.

EV is value attributable to all capital providers for operating assets; bridge with net debt and other non-equity claims.

Growth, risk, margins, capital intensity, cash conversion, market position and governance.

Potential control premiums and expected synergies, though market conditions and deal-specific factors matter.

It omits capex and working capital needs and may be distorted by leases, non-recurring items and accounting differences.

Revenue metrics with unit economics, asset value, scenario DCF and comparable transactions as appropriate.

Estimate combined net income, synergies, financing costs, share issuance and pro forma EPS versus acquirer standalone EPS.

Stable free cash flow, manageable capex, defensible margins, collateral, operational upside and credible exit options.

Entry multiple, leverage, EBITDA growth, free cash flow/debt paydown and exit multiple.

Cash financing affects interest income/debt expense; stock issuance dilutes ownership; compare after-tax costs and EPS.

A grid showing how EPS accretion/dilution changes with purchase premium, synergies, financing mix and cost of debt.

Control, synergies, strategic positioning and expected future cash flows, tempered by integration risk.

Evaluate cost, dilution, leverage capacity, ratings, covenants, market conditions and flexibility.

Financing costs and valuations may pressure volumes, while sector-specific and strategic factors can offset them.

Identify structural catalysts, likely buyers and sellers, valuation, regulation and financing constraints.

Use a current verified source, distinguish direct and second-order effects, and offer client implications.

Equity valuations, volatility, investor demand, interest rates, issuer readiness and the issuance pipeline.

Purchase price translation, financing, cash flows, hedging and post-close earnings.

Revenue durability, compute costs, IP ownership, security, regulation, customer concentration and integration.

Clarify objective, strategic fit, purchase price, funding, expected synergies, competition risks and value creation.

Lead with recommendation, show 2–3 key numbers, key sensitivities, risks and next steps.

Clarify deadlines and criticality, communicate early, propose sequencing and maintain quality checks.

Bridge assumptions, assess synergies, run sensitivities, compare market valuations and define walk-away terms.

Separate productivity opportunities from model risk, confidentiality, regulatory controls, human review and measurable ROI.

Ask about live deal responsibilities, team training, sector focus and what strong analysts do differently.